SP
TMO icon

Sarasin & Partners’s Thermo Fisher Scientific TMO Stock Holding History

Sarasin & Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$134M Buy
266,872
+17,018
+7% +$8.17M 1.57% 22
2026
Q1 		$123M Sell
249,854
-14,675
-6% -$7.96M 1.5% 24
2025
Q4 		$153M Sell
264,529
-3,878
-1% -$2.19M 1.59% 25
2025
Q3 		$124M Buy
268,407
+11,818
+5% +$5.5M 1.22% 28
2025
Q2 		$104M Sell
256,589
-119,485
-32% -$50M 1.04% 33
2025
Q1 		$187M Buy
+376,074
New +$204M 2.03% 23
2024
Q4 		– Sell
-488,325
Closed -$302M – 74
2024
Q3 		$302M Sell
488,325
-71,851
-13% -$42.5M 2.85% 17
2024
Q2 		$310M Buy
560,176
+100,383
+22% +$57.5M 2.74% 15
2024
Q1 		$267M Buy
459,793
+43,678
+10% +$24.5M 2.63% 15
2023
Q4 		$221M Buy
416,115
+50,372
+14% +$24.4M 2.43% 15
2023
Q3 		$185M Buy
365,743
+8,570
+2% +$4.57M 2.31% 17
2023
Q2 		$186M Buy
357,173
+114,497
+47% +$61.8M 2.16% 18
2023
Q1 		$140M Sell
242,676
-64,547
-21% -$36.4M 0.75% 43
2022
Q4 		$169M Buy
307,223
+29,865
+11% +$15.8M 2.22% 17
2022
Q3 		$141M Buy
277,358
+16,490
+6% +$9.23M 1.95% 19
2022
Q2 		$142M Buy
260,868
+125,631
+93% +$69.2M 1.79% 23
2022
Q1 		$79.9M Buy
+135,237
New +$77.7M 0.8% 39

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Sarasin & Partners's TMO Position: Q2 2026 in Review

Sarasin & Partners increased its Thermo Fisher Scientific (TMO) stake by 6.8% in Q2 2026, buying an estimated $8.17M and bringing the position to 266,872 shares worth $134M. The position accounts for 1.57% of the portfolio, ranked #22.

Sarasin & Partners first reported a position in TMO in Q1 2022 and has held it in 17 quarters since. The position peaked at $310M in Q2 2024. 1,040 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Sarasin & Partners held 266,872 shares of Thermo Fisher Scientific worth $134M as of Q2 2026.
  • Sarasin & Partners bought 17,018 Thermo Fisher Scientific shares in Q2 2026, an estimated $8.17M.
  • Thermo Fisher Scientific made up 1.57% of Sarasin & Partners's portfolio in Q2 2026, its #22 holding.
  • Sarasin & Partners first reported a position in Thermo Fisher Scientific in Q1 2022 and has held it in 17 quarters since.
  • Sarasin & Partners's Thermo Fisher Scientific position peaked at $310M in Q2 2024.
  • 1,040 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Sarasin & Partners's 13F filing for Q2 2026, filed 7 Jul 2026.